Published in Ann Neurol on December 01, 1988
The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol (1990) 2.19
Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy. PLoS One (2012) 1.15
The non-peptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats. Br J Pharmacol (1993) 1.10
CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges. Br J Pharmacol (1992) 1.10
Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater. Br J Pharmacol (1991) 1.02
CP-93,129, a potent and selective 5-HT1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea-pig dura mater. Br J Pharmacol (1991) 1.01
Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development. Proc Natl Acad Sci U S A (1994) 0.98
Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan. Br J Pharmacol (1991) 0.97
Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation. Br J Pharmacol (1995) 0.94
Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats. Br J Pharmacol (2001) 0.94
Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions. J Neurol (1991) 0.89
Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors. Br J Pharmacol (1991) 0.85
Time-dependent blockade of neurogenic plasma extravasation in dura mater by 5-HT1B/D agonists and endopeptidase 24.11. Br J Pharmacol (1993) 0.82
Pharmacology of antimigraine drugs. J Neurol (1991) 0.79
New concepts of vascular headache. Ann R Coll Surg Engl (1993) 0.77
Dural neurogenic inflammation induced by neuropathic pain is specific to cranial region. J Neural Transm (Vienna) (2013) 0.76
Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine. Brain (2016) 0.76
Trigeminal nerve ganglion stimulation-induced neurovascular reflexes in the anaesthetized cat: role of endothelin(B) receptors in carotid vasodilatation. Br J Pharmacol (1999) 0.76
Neuropeptide Y Y2 receptor-mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms. Br J Pharmacol (1996) 0.76
The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation. Br J Pharmacol (1995) 0.76
Verisimilitude (or "truthlikeness") as an alternative to pro and cons: migraine and cluster headache mechanisms. J Headache Pain (2010) 0.75
Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (1990) 11.18
Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci (1999) 10.61
Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature (1995) 9.86
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A (1998) 9.66
Measuring patients' desire for autonomy: decision making and information-seeking preferences among medical patients. J Gen Intern Med (1989) 7.41
Inadequate management of blood pressure in a hypertensive population. N Engl J Med (1998) 7.16
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res (1990) 5.70
Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science (1994) 5.15
Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci (2001) 4.99
Dynamic imaging of cerebral blood flow using laser speckle. J Cereb Blood Flow Metab (2001) 4.75
Relation of family responsibilities and gender to the productivity and career satisfaction of medical faculty. Ann Intern Med (1998) 4.52
KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet (1997) 4.46
Junior faculty members' mentoring relationships and their professional development in U.S. medical schools. Acad Med (1998) 4.18
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet (1996) 4.09
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet (1995) 4.01
Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature (1997) 3.70
Minority faculty and academic rank in medicine. JAMA (1998) 3.60
Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A (2001) 3.51
Black women receive less mammography even with similar use of primary care. Ann Intern Med (1996) 3.47
Excess number of bladder cancers in workers exposed to ortho-toluidine and aniline. J Natl Cancer Inst (1991) 3.40
Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res (1999) 3.40
Conversion of diploidy to haploidy. Nature (2000) 3.28
The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A (1993) 3.25
Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev (1998) 3.24
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (1998) 3.23
Mutations of GTBP in genetically unstable cells. Science (1995) 3.23
Statewide quality improvement initiatives and mortality after cardiac surgery. JAMA (1997) 3.16
Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med (1998) 3.06
Deletion of p16 and p15 genes in brain tumors. Cancer Res (1994) 3.03
Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med (1987) 3.00
Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci U S A (1997) 2.99
Evidence of a cerebrovascular postarteriole windkessel with delayed compliance. J Cereb Blood Flow Metab (1999) 2.93
A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci (1999) 2.92
The neurobiology of vascular head pain. Ann Neurol (1984) 2.89
Coding of acute myocardial infarction. Clinical and policy implications. Ann Intern Med (1988) 2.85
Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab (1996) 2.78
Attitudes toward colorectal cancer screening tests. J Gen Intern Med (2001) 2.56
Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci (1998) 2.55
A clinical assessment of MedisGroups. JAMA (1988) 2.50
Searching for an improved clinical comorbidity index for use with ICD-9-CM administrative data. J Clin Epidemiol (1996) 2.43
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res (1994) 2.39
The exclusion of non-English-speaking persons from research. J Gen Intern Med (1996) 2.37
Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab (1997) 2.31
The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol (1990) 2.19
Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J Neurosci (2000) 2.18
MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci U S A (1999) 2.16
Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res (1998) 2.16
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet (2000) 2.15
Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem (1995) 2.15
MRI measurement of the temporal evolution of relative CMRO(2) during rat forepaw stimulation. Magn Reson Med (1999) 2.15
Do-not-resuscitate orders at a chronic care hospital. J Am Geriatr Soc (1991) 2.07
Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut (2001) 2.05
Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J Cell Biol (2000) 2.04
Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J Cereb Blood Flow Metab (1996) 2.01
Specialty choices, compensation, and career satisfaction of underrepresented minority faculty in academic medicine. Acad Med (2000) 2.00
Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc Natl Acad Sci U S A (2001) 1.98
Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci (1987) 1.94
Use of hospital mortality rates to measure quality of care. J Am Geriatr Soc (1988) 1.91
FGF-2 regulation of neurogenesis in adult hippocampus after brain injury. Proc Natl Acad Sci U S A (2001) 1.90
Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J Exp Med (1997) 1.89
Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57black/6 mice. Stroke (1997) 1.89
Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res (1994) 1.82
Perfusion weighted imaging during migraine: spontaneous visual aura and headache. Cephalalgia (1999) 1.81
Deriving a risk-adjustment model for pressure ulcer development using the Minimum Data Set. J Am Geriatr Soc (2001) 1.78
Familial calcification of the basal ganglions: a metabolic and genetic study. N Engl J Med (1971) 1.78
Intraneuronal substance P contributes to the severity of experimental arthritis. Science (1984) 1.77
Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest (2000) 1.76
Rating long-term care facilities on pressure ulcer development: importance of case-mix adjustment. Ann Intern Med (1996) 1.75
BID mediates neuronal cell death after oxygen/ glucose deprivation and focal cerebral ischemia. Proc Natl Acad Sci U S A (2001) 1.74
Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J Cereb Blood Flow Metab (1998) 1.71
Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc (2000) 1.70
Nonmedical influences on medical decision making: an experimental technique using videotapes, factorial design, and survey sampling. Health Serv Res (1997) 1.70
Functional magnetic resonance imaging of reorganization in rat brain after stroke. Proc Natl Acad Sci U S A (2001) 1.69
The impact of leaving against medical advice on hospital resource utilization. J Gen Intern Med (2000) 1.64
Predicting in-hospital mortality. A comparison of severity measurement approaches. Med Care (1992) 1.60
Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J Neurosci (1999) 1.59
Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab (1994) 1.58
Variation in hospital rates of intraaortic balloon pump use in coronary artery bypass operations. Ann Thorac Surg (1999) 1.56
Evidence for apoptosis after intercerebral hemorrhage in rat striatum. J Cereb Blood Flow Metab (2000) 1.55
Illness severity and costs of admissions at teaching and nonteaching hospitals. JAMA (1990) 1.51
Polyphosphoinositide hydrolysis in endothelial cells and carotid artery segments. Bradykinin-2 receptor stimulation is calcium-independent. J Biol Chem (1986) 1.51
DNA methyltransferase contributes to delayed ischemic brain injury. J Neurosci (2000) 1.50
Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci U S A (1996) 1.49
Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man. Science (1981) 1.48
Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J Comp Neurol (1984) 1.47
Polymerase delta variants in RER colorectal tumours. Nat Genet (1995) 1.47
Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke (2001) 1.47
Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res (1996) 1.47
Hypothesis: the nervous system may contribute to the pathophysiology of rheumatoid arthritis. J Rheumatol (1985) 1.42
Variability in mammography use among older women. J Am Geriatr Soc (1996) 1.42
Patient assertiveness and physician decision-making among older breast cancer patients. Soc Sci Med (1999) 1.41
Comparing the status of women and men in academic medicine. Ann Intern Med (1993) 1.40
Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol (1998) 1.40
The importance of comorbidities in explaining differences in patient costs. Med Care (1996) 1.39
Blood components contribute to rise in gerbil brain levels of leukotriene-like immunoreactivity after ischemia and reperfusion. Stroke (1988) 1.39
Family breast cancer history and mammography: Framingham Offspring Study. Am J Epidemiol (2001) 1.38
Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. J Neurosci (1997) 1.38
Neuroprotective effects of gelsolin during murine stroke. J Clin Invest (1999) 1.38
Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor. Nature (1980) 1.35
Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages. Infect Immun (1991) 1.34